Skip to main content

Clinical TrialsSearch 1M+ trials from global registries Drug IntelligenceFollow pipelines from discovery to approval

Global ApprovalsTrack regulatory decisions across 12+ agencies

US FDA Drugs EU EMA Drugs Singapore HSA Drugs China NMPA Drugs Australia TGA Drugs Canada HC Drugs Spain CIMA-AEMPS Drugs UK EMC Drugs Saudi SFDA Drugs Malaysia NPRA Drugs Philippines FDA Drugs Kenya PPB Drugs

AI-Powered ResearchDiscover powerful insights with advanced AI analysis tools for clinical trials.Learn more →Premium AccessGet unlimited access to our comprehensive pharmaceutical database and analytics.Subscribe →

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR) - HSA Drug Approval Details

Approvals/HSA/CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

Approved

THERAPEUTIC

CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)

Delpharm Montréal Inc.🇸🇬 Health Sciences Authority

Approval Date: Jan 29, 2021
Approval ID: 9102b5ca22d9bac6
Company: Delpharm Montréal Inc.
Type: Therapeutic

Approval Details

Approval Id: 9102b5ca22d9bac6
Drug Name: CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)
Product Name: CLARITYNE SYRUP 5 MG/5 ML (GRAPE FLAVOR)
Approval Number: SIN16091P
Approval Date: 2021-01-29
Registrant: BAYER (SOUTH EAST ASIA) PTE LTD
Licence Holder: BAYER (SOUTH EAST ASIA) PTE LTD
Drug Type: Therapeutic
Forensic Classification: General Sale List
Dosage Form: SYRUP
Route Of Administration: ORAL
Atc Code: R06AX13
Atc Item Name: loratadine
Pharma Manufacturer Name: BAYER (SOUTH EAST ASIA) PTE LTD
Company Detail Path: /organization/cdf0085bd222bf2a/bayer-south-east-asia-pte-ltd

Active Ingredients

Loratadine

5 mg/ 5mL

LORATADINE

5 MG/5 ML

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Jan 29, 2021

Approval ID

9102b5ca22d9bac6

Type

Therapeutic

Back to HSA Approvals